1. 3 potential blockbusters under FDA review — AbbVie gets the most out of its workers — Roche/Exelixis’ Cotellic fizzles in melanoma study — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

Questions

Discussion in 'BioDelivery Sciences' started by anonymous, Sep 26, 2017 at 8:43 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Why isn't there a lot of information about this company online? Is it fairly new? How larger is the sales force? Are the territories pretty big?
     

  2. anonymous

    anonymous Guest

    Head hunters are calling some of us. How does this place compare to others. We know that no Pharma business is a shining star right now or in the eyes of the employees. Is it better, worse or about the same here? The kindness of any reply, not ranting, would be appreciated. And we all know to filter it a few times.

    Also is there a strategy to counter BuTrans going generic? Thanks!